Analysts Set The Chemours Company (NYSE:CC) PT at $18.00

The Chemours Company (NYSE:CC) has received an average rating of “Hold” from the twelve brokerages that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $18.40.

Several brokerages have recently issued reports on CC. Mizuho raised their price objective on Chemours from $17.00 to $21.00 and gave the stock an “outperform” rating in a research note on Thursday. JPMorgan Chase & Co. lifted their price objective on shares of Chemours from $13.00 to $17.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd. Morgan Stanley upped their price objective on shares of Chemours from $15.00 to $17.00 and gave the company an “equal weight” rating in a report on Monday, February 23rd. Truist Financial raised their target price on shares of Chemours from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, January 21st. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $18.00 price target on shares of Chemours in a report on Friday, January 16th.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Alpine Global Management LLC purchased a new stake in Chemours in the 4th quarter worth approximately $176,000. Invesco Ltd. lifted its stake in shares of Chemours by 14.0% in the 4th quarter. Invesco Ltd. now owns 948,125 shares of the specialty chemicals company’s stock valued at $11,178,000 after purchasing an additional 116,385 shares during the period. Corient Private Wealth LLC lifted its stake in shares of Chemours by 62.3% in the 4th quarter. Corient Private Wealth LLC now owns 31,399 shares of the specialty chemicals company’s stock valued at $370,000 after purchasing an additional 12,047 shares during the period. Mercer Global Advisors Inc. ADV purchased a new stake in Chemours during the fourth quarter worth $191,000. Finally, Empowered Funds LLC grew its position in Chemours by 7.8% during the fourth quarter. Empowered Funds LLC now owns 40,577 shares of the specialty chemicals company’s stock valued at $478,000 after buying an additional 2,936 shares during the period. 76.26% of the stock is owned by institutional investors and hedge funds.

Chemours Stock Performance

Shares of CC opened at $16.70 on Friday. The company has a current ratio of 1.78, a quick ratio of 0.85 and a debt-to-equity ratio of 16.33. The firm has a market cap of $2.51 billion, a PE ratio of -6.73 and a beta of 1.60. Chemours has a 12 month low of $9.13 and a 12 month high of $21.85. The stock has a fifty day moving average price of $16.29 and a 200-day moving average price of $14.73.

Chemours (NYSE:CC) last released its earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. Chemours’s revenue was down 2.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.09 EPS. Equities research analysts predict that Chemours will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Friday, February 27th will be paid a $0.0875 dividend. The ex-dividend date is Friday, February 27th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.1%. Chemours’s dividend payout ratio is presently -14.11%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.